Skip to main content
Clinical Trials/NL-OMON53882
NL-OMON53882Not yet recruitingPhase 2

Oxytocin and reactivity to infant signals in mothers postpartum depression - Oxytocin and Postpartum Depression

Radboud Universiteit Nijmegen0 sites35 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
35

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
0 to 64 (—)

Inclusion Criteria

  • Mothers with a healthy infant between 0 and 9 months of age
  • With a diagnosis of postpartum depression, that is, scores of >=7 on the
  • Edinburgh Postnatal Depression Scale and a postpartum depression diagnosis
  • confirmed through the Structured Clinical Interview for the DSM-5

Exclusion Criteria

  • Current mental disorder other than depression or an anxiety disorder
  • PPD with psychotic symptoms
  • Neurological disorders, endocrine diseases, cardiovascular diseases, nose
  • injuries and disorders, use of medication other than oral contraceptives or
  • anti-depressant medication
  • Regular use of soft drugs, hard drug use within the past three months, or
  • excessive alcohol intake
  • Pregnancy
  • Preterm birth (< 37 weeks)

Investigators

Similar Trials